ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q3 2021. The put-call ratio across all filers is 0.36 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,666 | -8.6% | 135,079 | +3.5% | 3.39% | +9.2% |
| Q2 2023 | $4,011 | -22.0% | 130,487 | -8.6% | 3.11% | -18.5% |
| Q1 2023 | $5,143 | +4.9% | 142,748 | +15.0% | 3.81% | -2.8% |
| Q4 2022 | $4,904 | -99.9% | 124,090 | -9.6% | 3.92% | -10.0% |
| Q3 2022 | $5,513,000 | -12.2% | 137,206 | -8.2% | 4.35% | +2.8% |
| Q2 2022 | $6,280,000 | -26.4% | 149,389 | -25.6% | 4.24% | +10.9% |
| Q1 2022 | $8,527,000 | +6.6% | 200,692 | 0.0% | 3.82% | +0.4% |
| Q4 2021 | $7,998,000 | +13.9% | 200,692 | +3.3% | 3.81% | +18.5% |
| Q3 2021 | $7,022,000 | +75.4% | 194,305 | +99.0% | 3.21% | +69.7% |
| Q2 2021 | $4,003,000 | – | 97,656 | – | 1.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
| Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
| HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
| ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
| Brown University | 381,759 | $16,652,000 | 11.44% |
| Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
| SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
| Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
| Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |